Columbia University Medical Center (CUMC) researchers have found that a single dose of ketamine, given one week before a stressful event, can buffer against a heightened fear response.
The study, conducted in mice, suggests that prophylactic administration of ketamine—a drug commonly used as a general anesthetic or a rapid-acting antidepressant—might prevent post-traumatic stress disorder (PTSD) symptoms in soldiers and others who subsequently experience psychological trauma.
The study was published online in January in the journal Neuropsychopharmacology.
Journal article:https://www.nature.com/npp/journal/v42/n8/full/npp201719a.html
Source and further reading:http://newsroom.cumc.columbia.edu/blog/2017/02/08/ptsd-symptoms-may-prevented-ketamine/
Source: Corina Marinescu
No comments:
Post a Comment